Please ensure Javascript is enabled for purposes of website accessibility

Why Amazon Won't Sell You a N95 Surgical Mask or COVID-19 Test Kit Anymore

By Donna Fuscaldo – Apr 2, 2020 at 3:13PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The e-commerce giant is now reserving those vital supplies for medical institutions and government organizations.

Given the worldwide shortages of N95 surgical masks and coronavirus diagnostic kits, Amazon (AMZN -0.54%) has decided to halt all sales of those two medical supplies to consumers. 

Instead, Amazon said it is prioritizing sales of N95 masks and COVID-19 test kits to hospitals and government agencies, Earlier in the week, it debuted a new section of its website where hospitals and government organizations can order vital COVID-19 related products including masks and tests. 

N95 masks, surgical masks and sanitizer on table.


Amazon said it will not be making a profit from those sales, and that it's waiving its standard referral fees for third-party sellers on products used to help slow the spread of COVID-19. Amazon said it's not accepting requests from individuals or non-qualified organizations.

The e-commerce giant has also turned to its third-party sellers for help in getting these important medical supplies to healthcare providers. In a message to sellers, Amazon urged them to make additional inventory of N95 masks, surgical masks, facial shields, surgical gowns, gloves and large-volume sanitizers available at competitive prices. 

An Amazon spokesperson told CNBC that its goal is to ensure these vital supplies reach the organizations that need them during the pandemic. Members of the public will still be able to purchase small volumes of hand sanitizers and wipes on its e-commerce site. 

With the number of COVID cases in the U.S. surpassing 235,000, hospitals around the country have been warning they either have run out of key supplies or will run out shortly. Amazon in mid-March took the step of blocking all new third-party listings for face masks and sanitizers as part of its efforts clamp down on price gouging

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Donna Fuscaldo has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Amazon and recommends the following options: short January 2022 $1940 calls on Amazon and long January 2022 $1920 calls on Amazon. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned, Inc. Stock Quote, Inc.
$120.30 (-0.54%) $0.65

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.